Zobrazeno 1 - 3
of 3
pro vyhledávání: '"A. C. Inge Boullart"'
Autor:
J. Han J.M. vanKrieken, A. C. Inge Boullart, Cornelis J. A. Punt, Willeke A. M. Blokx, Johannes J. Bonenkamp, Ellemieke Kok, Carl G. Figdor, W. Joost Lesterhuis, I. Jolanda M. de Vries, Wim J.G. Oyen, Otto C. Boerman, Gosse J. Adema, Michelle M. van Rossum, Pauline Verdijk, Erik H.J.G. Aarntzen, Joannes F M Jacobs, Femke Eijckeler, Irma Joosten, S. P. Strijk
Publikováno v:
Clinical Cancer Research, 15, 7, pp. 2531-40
Clinical cancer research, 15(7), 2531-2540. American Association for Cancer Research Inc.
Clinical Cancer Research, 15, 2531-40
Clinical cancer research, 15(7), 2531-2540. American Association for Cancer Research Inc.
Clinical Cancer Research, 15, 2531-40
Purpose: The success of immunotherapy with dendritic cells (DC) to treat cancer is dependent on effective migration to the lymph nodes and subsequent activation of antigen-specific T cells. In this study, we investigated the fate of DC after intrader
Autor:
Carl G. Figdor, I. Jolanda M. de Vries, Cornelis J. A. Punt, Gosse J. Adema, Erik H.J.G. Aarntzen, A. C. Inge Boullart, Maaike G. M. Looman, Matthijs Kramer, W. Joost Lesterhuis, Gerty Schreibelt, Daniel Benitez-Ribas, Danita H. Schuurhuis, Maaike A. van Hout-Kuijer
Publikováno v:
Cancer Immunology Immunotherapy, 58, 7, pp. 1109-15
Cancer immunology, immunotherapy, 58(7), 1109-1115. Springer Science and Business Media Deutschland GmbH
Cancer Immunology Immunotherapy, 58, 1109-15
Cancer immunology, immunotherapy, 58(7), 1109-1115. Springer Science and Business Media Deutschland GmbH
Cancer Immunology Immunotherapy, 58, 1109-15
Contains fulltext : 79503.pdf (Publisher’s version ) (Open Access) Tumor-derived peptides are used frequently as antigen (Ag) source in dendritic cell (DC) therapy in cancer patients. An alternative is to load DC with tumor-associated Ag (TAA)-enco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a905712e71a4721ab594e9857731e68
https://hdl.handle.net/2066/79503
https://hdl.handle.net/2066/79503
Autor:
Mandy W.M.M. van de Rakt, Carl G. Figdor, I. Jolanda M. de Vries, Gosse J. Adema, Nicole M. Scharenborg, Joannes F M Jacobs, A. C. Inge Boullart, Cornelis J. A. Punt, Daniel Benitez-Ribas, Matthijs Kramer, Gerty Schreibelt, Erik H.J.G. Aarntzen, Danita H. Schuurhuis, Annemiek J. de Boer, Pauline Verdijk
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology Immunotherapy, 57, 1589-97
Cancer immunology, immunotherapy, 57(11), 1589-1597. Springer Science and Business Media Deutschland GmbH
Cancer Immunology Immunotherapy, 57, 11, pp. 1589-97
Cancer Immunology Immunotherapy, 57, 1589-97
Cancer immunology, immunotherapy, 57(11), 1589-1597. Springer Science and Business Media Deutschland GmbH
Cancer Immunology Immunotherapy, 57, 11, pp. 1589-97
Dendritic cells (DC) are professional antigen-presenting cells of the immune system that play a key role in regulating T cell-based immunity. In vivo, the capacity of DC to activate T cells depends on their ability to migrate to the T cell areas of l